(Total Views: 218)
Posted On: 06/23/2020 10:10:47 AM
Post# of 38564
$XRTXF
Add Anthony J. Giovinazzo
XORTX’s two key programs in autosomal dominant polycystic #kidneydisease (ADPKD) and the treatment of acute kidney injury due to #coronavirus COVID-19 infection are advancing toward clinical trial initiation. https://finance.yahoo.com/news/xortx-announce...10595.html
Add Anthony J. Giovinazzo
XORTX’s two key programs in autosomal dominant polycystic #kidneydisease (ADPKD) and the treatment of acute kidney injury due to #coronavirus COVID-19 infection are advancing toward clinical trial initiation. https://finance.yahoo.com/news/xortx-announce...10595.html
(0)
(0)
